The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Companion Animal Pharmaceutical Market Research Report 2022

Global Companion Animal Pharmaceutical Market Research Report 2022

Publishing Date : Jul, 2022

License Type :
 

Report Code : 1721860

No of Pages : 88

Synopsis
Market Analysis and Insights: Global Companion Animal Pharmaceutical Market
Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
The global Companion Animal Pharmaceutical market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Infectious Diseases accounting for % of the Companion Animal Pharmaceutical global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Dogs segment is altered to an % CAGR throughout this forecast period.
China Companion Animal Pharmaceutical market size is valued at US$ million in 2021, while the North America and Europe Companion Animal Pharmaceutical are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Companion Animal Pharmaceutical landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Animal Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Animal Pharmaceutical market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Animal Pharmaceutical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Animal Pharmaceutical market.
Global Companion Animal Pharmaceutical Scope and Market Size
Companion Animal Pharmaceutical market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Companion Animal Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other Indications
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animal Pharmaceutical Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Infectious Diseases
1.2.3 Dermatologic Diseases
1.2.4 Pain
1.2.5 Orthopedic Diseases
1.2.6 Behavioral Diseases
1.2.7 Other Indications
1.3 Market by Application
1.3.1 Global Companion Animal Pharmaceutical Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Animal Pharmaceutical Market Perspective (2017-2028)
2.2 Companion Animal Pharmaceutical Growth Trends by Region
2.2.1 Companion Animal Pharmaceutical Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Companion Animal Pharmaceutical Historic Market Size by Region (2017-2022)
2.2.3 Companion Animal Pharmaceutical Forecasted Market Size by Region (2023-2028)
2.3 Companion Animal Pharmaceutical Market Dynamics
2.3.1 Companion Animal Pharmaceutical Industry Trends
2.3.2 Companion Animal Pharmaceutical Market Drivers
2.3.3 Companion Animal Pharmaceutical Market Challenges
2.3.4 Companion Animal Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animal Pharmaceutical Players by Revenue
3.1.1 Global Top Companion Animal Pharmaceutical Players by Revenue (2017-2022)
3.1.2 Global Companion Animal Pharmaceutical Revenue Market Share by Players (2017-2022)
3.2 Global Companion Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Animal Pharmaceutical Revenue
3.4 Global Companion Animal Pharmaceutical Market Concentration Ratio
3.4.1 Global Companion Animal Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Pharmaceutical Revenue in 2021
3.5 Companion Animal Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Companion Animal Pharmaceutical Product Solution and Service
3.7 Date of Enter into Companion Animal Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animal Pharmaceutical Breakdown Data by Type
4.1 Global Companion Animal Pharmaceutical Historic Market Size by Type (2017-2022)
4.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Type (2023-2028)
5 Companion Animal Pharmaceutical Breakdown Data by Application
5.1 Global Companion Animal Pharmaceutical Historic Market Size by Application (2017-2022)
5.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Animal Pharmaceutical Market Size (2017-2028)
6.2 North America Companion Animal Pharmaceutical Market Size by Country (2017-2022)
6.3 North America Companion Animal Pharmaceutical Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Companion Animal Pharmaceutical Market Size (2017-2028)
7.2 Europe Companion Animal Pharmaceutical Market Size by Country (2017-2022)
7.3 Europe Companion Animal Pharmaceutical Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Pharmaceutical Market Size (2017-2028)
8.2 Asia-Pacific Companion Animal Pharmaceutical Market Size by Country (2017-2022)
8.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Companion Animal Pharmaceutical Market Size (2017-2028)
9.2 Latin America Companion Animal Pharmaceutical Market Size by Country (2017-2022)
9.3 Latin America Companion Animal Pharmaceutical Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Pharmaceutical Market Size (2017-2028)
10.2 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2017-2022)
10.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animal Pharmaceutical Introduction
11.1.4 Zoetis Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Companion Animal Pharmaceutical Introduction
11.2.4 Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Detail
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Companion Animal Pharmaceutical Introduction
11.3.4 Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Detail
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Companion Animal Pharmaceutical Introduction
11.4.4 Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Detail
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Companion Animal Pharmaceutical Introduction
11.5.4 Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.5.5 Bayer Animal Health Recent Development
11.6 Virbac
11.6.1 Virbac Company Detail
11.6.2 Virbac Business Overview
11.6.3 Virbac Companion Animal Pharmaceutical Introduction
11.6.4 Virbac Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.6.5 Virbac Recent Development
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Detail
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Companion Animal Pharmaceutical Introduction
11.7.4 Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.7.5 Dechra Veterinary Products Recent Development
11.8 Ceva
11.8.1 Ceva Company Detail
11.8.2 Ceva Business Overview
11.8.3 Ceva Companion Animal Pharmaceutical Introduction
11.8.4 Ceva Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Detail
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Companion Animal Pharmaceutical Introduction
11.9.4 Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.9.5 Vetoquinol Recent Development
11.10 Meiji
11.10.1 Meiji Company Detail
11.10.2 Meiji Business Overview
11.10.3 Meiji Companion Animal Pharmaceutical Introduction
11.10.4 Meiji Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.10.5 Meiji Recent Development
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Detail
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Companion Animal Pharmaceutical Introduction
11.11.4 Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.11.5 Ouro Fino Saude Recent Development
11.12 Parnell
11.12.1 Parnell Company Detail
11.12.2 Parnell Business Overview
11.12.3 Parnell Companion Animal Pharmaceutical Introduction
11.12.4 Parnell Revenue in Companion Animal Pharmaceutical Business (2017-2022)
11.12.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Companion Animal Pharmaceutical Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Infectious Diseases
Table 3. Key Players of Dermatologic Diseases
Table 4. Key Players of Pain
Table 5. Key Players of Orthopedic Diseases
Table 6. Key Players of Behavioral Diseases
Table 7. Key Players of Other Indications
Table 8. Global Companion Animal Pharmaceutical Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Companion Animal Pharmaceutical Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Companion Animal Pharmaceutical Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Companion Animal Pharmaceutical Market Share by Region (2017-2022)
Table 12. Global Companion Animal Pharmaceutical Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Companion Animal Pharmaceutical Market Share by Region (2023-2028)
Table 14. Companion Animal Pharmaceutical Market Trends
Table 15. Companion Animal Pharmaceutical Market Drivers
Table 16. Companion Animal Pharmaceutical Market Challenges
Table 17. Companion Animal Pharmaceutical Market Restraints
Table 18. Global Companion Animal Pharmaceutical Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Companion Animal Pharmaceutical Market Share by Players (2017-2022)
Table 20. Global Top Companion Animal Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Pharmaceutical as of 2021)
Table 21. Ranking of Global Top Companion Animal Pharmaceutical Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Companion Animal Pharmaceutical Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Companion Animal Pharmaceutical Product Solution and Service
Table 25. Date of Enter into Companion Animal Pharmaceutical Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Companion Animal Pharmaceutical Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Companion Animal Pharmaceutical Revenue Market Share by Type (2017-2022)
Table 29. Global Companion Animal Pharmaceutical Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Companion Animal Pharmaceutical Revenue Market Share by Type (2023-2028)
Table 31. Global Companion Animal Pharmaceutical Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2017-2022)
Table 33. Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2023-2028)
Table 35. North America Companion Animal Pharmaceutical Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Companion Animal Pharmaceutical Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Companion Animal Pharmaceutical Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Companion Animal Pharmaceutical Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Companion Animal Pharmaceutical Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Companion Animal Pharmaceutical Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Companion Animal Pharmaceutical Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2023-2028) & (US$ Million)
Table 45. Zoetis Company Detail
Table 46. Zoetis Business Overview
Table 47. Zoetis Companion Animal Pharmaceutical Product
Table 48. Zoetis Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 49. Zoetis Recent Development
Table 50. Boehringer Ingelheim Company Detail
Table 51. Boehringer Ingelheim Business Overview
Table 52. Boehringer Ingelheim Companion Animal Pharmaceutical Product
Table 53. Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 54. Boehringer Ingelheim Recent Development
Table 55. Merck Animal Health Company Detail
Table 56. Merck Animal Health Business Overview
Table 57. Merck Animal Health Companion Animal Pharmaceutical Product
Table 58. Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 59. Merck Animal Health Recent Development
Table 60. Elanco Animal Health Company Detail
Table 61. Elanco Animal Health Business Overview
Table 62. Elanco Animal Health Companion Animal Pharmaceutical Product
Table 63. Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 64. Elanco Animal Health Recent Development
Table 65. Bayer Animal Health Company Detail
Table 66. Bayer Animal Health Business Overview
Table 67. Bayer Animal Health Companion Animal Pharmaceutical Product
Table 68. Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 69. Bayer Animal Health Recent Development
Table 70. Virbac Company Detail
Table 71. Virbac Business Overview
Table 72. Virbac Companion Animal Pharmaceutical Product
Table 73. Virbac Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 74. Virbac Recent Development
Table 75. Dechra Veterinary Products Company Detail
Table 76. Dechra Veterinary Products Business Overview
Table 77. Dechra Veterinary Products Companion Animal Pharmaceutical Product
Table 78. Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 79. Dechra Veterinary Products Recent Development
Table 80. Ceva Company Detail
Table 81. Ceva Business Overview
Table 82. Ceva Companion Animal Pharmaceutical Product
Table 83. Ceva Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 84. Ceva Recent Development
Table 85. Vetoquinol Company Detail
Table 86. Vetoquinol Business Overview
Table 87. Vetoquinol Companion Animal Pharmaceutical Product
Table 88. Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 89. Vetoquinol Recent Development
Table 90. Meiji Company Detail
Table 91. Meiji Business Overview
Table 92. Meiji Companion Animal Pharmaceutical Product
Table 93. Meiji Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 94. Meiji Recent Development
Table 95. Ouro Fino Saude Company Detail
Table 96. Ouro Fino Saude Business Overview
Table 97. Ouro Fino Saude Companion Animal PharmaceuticalProduct
Table 98. Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 99. Ouro Fino Saude Recent Development
Table 100. Parnell Company Detail
Table 101. Parnell Business Overview
Table 102. Parnell Companion Animal PharmaceuticalProduct
Table 103. Parnell Revenue in Companion Animal Pharmaceutical Business (2017-2022) & (US$ Million)
Table 104. Parnell Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Animal Pharmaceutical Market Share by Type: 2021 VS 2028
Figure 2. Infectious Diseases Features
Figure 3. Dermatologic Diseases Features
Figure 4. Pain Features
Figure 5. Orthopedic Diseases Features
Figure 6. Behavioral Diseases Features
Figure 7. Other Indications Features
Figure 8. Global Companion Animal Pharmaceutical Market Share by Application in 2021 & 2028
Figure 9. Dogs Case Studies
Figure 10. Cats Case Studies
Figure 11. Other Case Studies
Figure 12. Companion Animal Pharmaceutical Report Years Considered
Figure 13. Global Companion Animal Pharmaceutical Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Companion Animal Pharmaceutical Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Companion Animal Pharmaceutical Market Share by Region: 2021 VS 2028
Figure 16. Global Companion Animal Pharmaceutical Market Share by Players in 2021
Figure 17. Global Top Companion Animal Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Pharmaceutical as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Companion Animal Pharmaceutical Revenue in 2021
Figure 19. North America Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Companion Animal Pharmaceutical Market Share by Country (2017-2028)
Figure 21. United States Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Companion Animal Pharmaceutical Market Share by Country (2017-2028)
Figure 25. Germany Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Companion Animal Pharmaceutical Market Share by Region (2017-2028)
Figure 33. China Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Companion Animal Pharmaceutical Market Share by Country (2017-2028)
Figure 41. Mexico Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Companion Animal Pharmaceutical Market Share by Country (2017-2028)
Figure 45. Turkey Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Companion Animal Pharmaceutical Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Zoetis Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 49. Merck Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 50. Elanco Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 51. Bayer Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 52. Virbac Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 53. Dechra Veterinary Products Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 54. Ceva Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 55. Vetoquinol Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 56. Meiji Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 57. Ouro Fino Saude Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 58. Parnell Revenue Growth Rate in Companion Animal Pharmaceutical Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’